I. Foster Cheek - 09 Aug 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Director
Signature
/s/ William Cook, as Attorney-in-fact for Kaye Foster
Issuer symbol
AGIO
Transactions as of
09 Aug 2023
Net transactions value
-$196,638
Form type
4
Filing time
11 Aug 2023, 16:04:51 UTC
Previous filing
23 Jun 2023
Next filing
07 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $452,250 +25,000 +217% $18.09 36,524 09 Aug 2023 Direct
transaction AGIO Common stock Sale $648,888 -25,000 -68% $25.96 11,524 09 Aug 2023 Direct F1
holding AGIO Common stock 2,200 09 Aug 2023 By Foster Family Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Stock options (right to buy) Options Exercise $0 -25,000 -85% $0.000000 4,307 09 Aug 2023 Common stock 25,000 $18.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.69 to $26.37. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023.